Evidence map›Paper›PMID 35717635›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Prevalence, Outcome, and Prevention of Congenital Cytomegalovirus Infection in Neonates Born to Women With Preconception Immunity (CHILd Study).

Daniele Lilleri, Beatrice Tassis, Lorenza Pugni, Andrea Ronchi, Carlo Pietrasanta, Arsenio Spinillo, Alessia Arossa, Cristian Achille, Patrizia Vergani, Sara Ornaghi and 24 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03973359 (Incidence, Outcome and Prevention of Congenital Human Cytomegalovirus), which is not on this map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03973359 naunknown statusnot on this map

Incidence, Outcome and Prevention of Congenital Human Cytomegalovirus (HCMV) Infection in HCMV-seropositive Pregnant Women

TypeinterventionalSponsorFondazione IRCCS Policlinico San Matteo di PaviaRan2017 to 2020Enrolled23,500ConditionsCongenital Cytomegalovirus Infection, Maternal Cytomegalovirus InfectionArmsHygienic recommendations
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.

  1. Guideline
  2. Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2023
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 9 institutions in 1 country.

Daniele LilleriMicrobiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID 0000-0001-7747-7622
Beatrice TassisFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Lorenza PugniFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Andrea RonchiFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Carlo PietrasantaFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Arsenio SpinilloOstetricia e Ginecologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Alessia ArossaOstetricia e Ginecologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Cristian AchilleNeonatologia e Terapia intensiva neonatale, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Patrizia VerganiFondazione Monza Brianza per il Bambino e la sua Mamma Onlus c/o Ospedale San Gerardo, Università Milano-Bicocca Scuola di Medicina e Chirurgia, Monza, Italy.
Sara OrnaghiFondazione Monza Brianza per il Bambino e la sua Mamma Onlus c/o Ospedale San Gerardo, Università Milano-Bicocca Scuola di Medicina e Chirurgia, Monza, Italy.
Silvia RiboniFondazione Monza Brianza per il Bambino e la sua Mamma Onlus c/o Ospedale San Gerardo, Università Milano-Bicocca Scuola di Medicina e Chirurgia, Monza, Italy.
Paolo CavorettoGynecology and Obstetrics Department, IRCCS San Raffaele Hospital and University, Milan, Italy.
Massimo CandianiGynecology and Obstetrics Department, IRCCS San Raffaele Hospital and University, Milan, Italy.
Gerarda GaetaGynecology and Obstetrics Department, IRCCS San Raffaele Hospital and University, Milan, Italy.
Federico PrefumoASST Spedali Civili di Brescia and University of Brescia, Brescia, Italy.
Nicola FratelliASST Spedali Civili di Brescia and University of Brescia, Brescia, Italy.
Anna FicheraASST Spedali Civili di Brescia and University of Brescia, Brescia, Italy.
Michele VignaliASST Fatebenefratelli-Sacco, Ospedale Macedonio Melloni, Milan, Italy.
Allegra Barbasetti Di PrunASST Fatebenefratelli-Sacco, Ospedale Macedonio Melloni, Milan, Italy.
Elisa FabbriDipartimento di Ostetricia e Ginecologia, Ospedale dei Bambini Vittore Buzzi, Università di Milano, Milan, Italy.
Irene CetinDipartimento di Ostetricia e Ginecologia, Ospedale dei Bambini Vittore Buzzi, Università di Milano, Milan, Italy.
Anna LocatelliASST Brianza (Ospedali di Carate e Vimercate), Vimercate, Italy.
Sara ConsonniASST Brianza (Ospedali di Carate e Vimercate), Vimercate, Italy.
Simona RutoloASST Monza, Ospedale di Desio, Desio, Italy.
Elena MiottoASST Monza, Ospedale di Desio, Desio, Italy.
Valeria SavasiUnit of Obstetrics and Gynecology, ASST Fatebenefratelli-Sacco, Milan, Italy.
Maria Di GiminianiUnit of Obstetrics and Gynecology, ASST Fatebenefratelli-Sacco, Milan, Italy.
Antonella CromiOspedale Del Ponte, Università dell'Insubria, Varese, Italy.
Sandro BindaDipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.
Loretta FiorinaMicrobiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Milena FurioneMicrobiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Gabriela CassinelliMicrobiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Catherine KlersyEpidemiologia clinica e Biostatistica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
CHILd Study Group
Policlinico San Matteo Fondazione · ITUniversity of Milan · ITAzienda Ospedaliera San Gerardo · ITVita-Salute San Raffaele University · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITOspedale dei Bambini Vittore Buzzi · ITAzienda Ospedaliera di Desio e Vimercate · ITUniversity of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman cytomegalovirus (HCMV) is the leading infectious cause of congenital disabilities. We designed a prospective study to investigate the rate, outcome, and risk factors of congenital CMV (cCMV) infection in neonates born to immune women, and the potential need and effectiveness of hygiene recommendations in this population.

methodsThe study was composed of 2 sequential parts: an epidemiology (part 1) and a prevention (part 2) study. Performance of part 2 depended upon a cCMV rate >0.4%. Women enrolled in part 1 did not receive hygiene recommendations. Newborns were screened by HCMV DNA testing in saliva and cCMV was confirmed by urine testing.

resultsSaliva swabs were positive for HCMV DNA in 45/9661 newborns and cCMV was confirmed in 18 cases. The rate of cCMV was .19% (95% confidence interval [CI]: .11-.29%), and 3 out of 18 infants with cCMV had symptoms of CMV at birth. Age, nationality, occupation, and contact with children were similar between mothers of infected and noninfected newborns. Twin pregnancy (odds ratio [OR]: 7.2; 95% CI: 1.7-32.2; P = .037) and maternal medical conditions (OR: 3.9; 95% CI: 1.5-10.1; P = .003) appeared associated with cCMV. Given the rate of cCMV was lower than expected, the prevention part of the study was cancelled.

conclusionsNewborns from women with preconception immunity have a low rate of cCMV, which appears to be mostly due to reactivation of the latent virus. Therefore, serological screening in childbearing age would be pivotal to identify HCMV-seropositive women, whose newborns have a low risk of cCMV. CLINICAL TRIALS REGISTRATION: www.clinicaltrials.gov (NCT03973359).

Indexed as

Cytomegalovirus InfectionsPregnancy Complications, InfectiousChildCytomegalovirusFemaleHumansInfantInfant, NewbornPregnancyPrevalenceProspective StudiesRisk Factorscongenital infectionhuman cytomegalovirusnonprimary infectionpreconception immunity

Identifiers

PMID35717635
PMCPMC9907511
OpenAlexW4283118726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.